2-((4-Cyanophenyl)amino)acetic acid

We are 2-((4-Cyanophenyl)amino)acetic acid CAS:42288-26-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-((4-Cyanophenyl)amino)acetic acid
CAS.NO:42288-26-6
Synonyms:N-(4-Cyano-Phenyl)-Glycine
N-(4-Cyanophenyl)glycine
Molecular Formula:C9H8N2O2
Molecular Weight:176.17200
 
Physical and Chemical Properties:
Density:1.3
Boiling point:447.2ºC
Flash point:224.3ºC
Index of Refraction:1.593
 
Specification:
Appearance:Off-white or pale yellow crystalline
Purity:≥98.0%
4-Amino benzonitrile:≤1.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Dabigatran etexilate
 
Note:The product under valid patents will not be offered to the countries covered by patents.

2-((4-Cyanophenyl)amino)acetic acid


Related News: Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.Tetrahidrocloruro de 1,4,7,10-tetraazaciclododecano CAS:10045-25-7 The fine and functional chemicals sector provides new growth drivers.34626-51-2 Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.trans-1,4-Dibromo-2-butene Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.

Related Products
Product Name
2-Amino-4,6-dimethylpyrimidine View Details
2′-Deoxyadenosine-5′-monophosphate disodium salt View Details
2-Propionylthiazole View Details
Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate manufacturer 1,3,5-Benzenetricarboxylic acid chloride manufacturer glutaric acid manufacturer N-phenyl-[1,1′,4′,1”-terphenyl]-4-amine manufacturer tert-butyl N-[(2R)-1-hydroxy-3-phenylmethoxypropan-2-yl]carbamate manufacturer